Intervention News

Teleflex and its subsidiary Arrow International issued a recall of its intra-aortic balloon catheter kits due to a manufacturing error that may cause the balloon to become overtwisted.

PHILADELPHIA — In patients with acute MI who had successful PCI and underwent imaging to assess plaque composition, diabetes raised risk for poor outcomes but the difference was not related to plaque, according to a presentation.

Much of the mortality in rheumatic heart disease was attributable to heart failure, and was significantly reduced by interventional treatment, which may stand as a barrier to improving mortality in lower-income countries, data show.

In two trials, OCT-guided PCI demonstrated superiority in imaging endpoints and improved procedural success compared with angiography and fluoroscopy alone, speakers reported.

In this Healio video exclusive, J. Dawn Abbott, MD, FSCAI, and James B. Hermiller, MD, MSCAI, discuss the impactful research and highlights from the 2024 Society for Cardiovascular Angiography and Interventions Scientific Sessions.

Transcatheter aortic valve replacement was associated with similar long-term mortality and stroke risk vs. surgery for severe aortic stenosis, but with greater risk for pacemaker implant with self-expanding TAVR valves, a speaker reported.

A new prosthetic aortic valve with a wider range of intermediate sizing was noninferior at 30 days vs. other contemporary transcatheter aortic valves, a speaker reported.

In younger patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement was associated with similar outcomes to surgical AVR, except in those with bicuspid valves, researchers reported.

In women with severe aortic stenosis and small aortic annuli who underwent transcatheter aortic valve replacement, a self-expanding valve was linked with better hemodynamic outcomes vs. a balloon-expandable valve at 1 year.

In patients with ACS who underwent PCI with a drug-coated balloon, an antiplatelet therapy de-escalation strategy was noninferior to 12-month dual antiplatelet therapy, researchers reported at EuroPCR.